Calcium salt urolithiasis

Clinical Nephrology

Volumn 51, Issue 4, 1999, Pages 197-208

  Gyory A Z ^a,c   Ashby, R ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Calcium oxalate; Calcium phosphate; Calculated risk index (SEQUIL); Crystallization agglomeration; Kidney stone disease; Metastable urine; Therapy; Urine equilibrium

Indexed keywords

CALCIUM SALT; CITRIC ACID;

ADULT; AGED; ALGORITHM; CALCIUM STONE; CRYSTALLIZATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL CHEMISTRY; REVIEW; STONE FORMATION; URINE; URINE PH; UROLITHIASIS;

ALGORITHMS; CALCIUM OXALATE; CALCIUM PHOSPHATES; CRYSTALLIZATION; HUMANS; MODELS, BIOLOGICAL; URINARY CALCULI;

EID: 17444435173     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Andrews JC, Yrabro CL, Golby RL, Sell IT 1955 Studies on the mechanism of formation of renal calculi. J Urol 73: 930-937
2. Ashby R 1995 The chemistry of sialoliths - stones and their homes. In:Norman J, Ede B, McGurk M(eds): Color Atlas and Text of the Salivary Glands. Mosby Wolfe, London, pp 243-252
3. Ashby R, Györy AZ 1997 A thermodynamic equilibrium model for calcium salt urolithiasis: clinical approach. Experiment Nephrol 5: 246-252
4. Ashby R, Sleet RJ 1992 The role of citrate complexes in preventing urolithiasis. Clin Chim Acta 210: 157-165
5. Asplin JR, Arsenault D, Parks JH, Coe FL, Hoyer JR 1998 Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int 53: 194-199
6. Borghi L, Meschi T, Amato F, Briganti AN, Gianni A 1996 Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5 year randomized prospective study. J Urol 155: 839-843
7. Brown CM, Achermann DK, Purich DL 1994 EQUIL93: a tool for experimental and clinical urolithiasis. Urol Res 22: 119
8. Consensus Conference 1988 Prevention and treatment of kidney stones. J Amer Med Assoc 260: 977
9. Crowley DM, McWinney BC, Brown JM, Chalmers AH 1987 Chemical factors important to calcium nephrolithiasis: evidence for impaired hydroxycarboxylic acid absorption causing hyperoxaluria. Clin Chem 33: 243-247
10. Curreri PA, Onoda CT, Finlayson B 1971 A comparative appraisal of adsorption of citrate on whewellite seed crystals. J Crystal Growth 53: 209-212
11. Curreri PA, Onoda CT, Finlayson B 1979 An electrophoretic study of calcium oxalate monohydrate. J Colloid and Interface Science 69: 170-182
12. Daniele PG, Marangella M 1982 Ionic equilibria in urine: a computer model system improved by accurate stability constant value. Ann Chim 72: 25-38
13. Finlayson B 1977 Calcium Stones, some physical and clinical aspects. In: David S: Calcium Metabolism in Renal Failure and Nephrolithiasis. John Wiley and Sons, New York, pp 337-382
14. Finlayson B 1978 Physicochemical aspects of urolithiasis. Kidney Int 13: 344-360
15. 14C-oxalate technique Invest Urol 12: 203
16. Györy AZ, Ashby R 1997 Equilibrium vs supersaturated urine hypothesis in calcium salt urolithiasis: a new theoretical and practical approach to a clinical problem. Scanning Microscopy 11: 1-5
17. Hwang TI, Preminger GM, Poindexter J, Pak CYC 1988 Urinary glycosaminoglycans in normal and patients with stones. J Urol 139: 995-997
18. Kissin B, Locks MO 1941 Urinary citrates in calcium urolithiasis. Proc Soc Exp Biol Med 46: 216-218
19. Kok DJ, Khan SR 1994 Calcium oxalate nephrolithiasis, a free or fixed particle disease. 46: 547-854
20. Kok DJ, Papapoulos SE, Bijvoet OLM 1986 Excessive crystal agglomeration with low citrate in recurrent stone-formers. Lancet I: 1056-1058
21. Kok DJ, Papapoulos SE, Blomen LJMJ, Bijvoet OLM 1988 Modulation of calcium oxalate monhydrate crystallisation kinetics in vitro. Kidney Int 34: 346-350
22. Kok DJ, Papapoulos SE, Bijvoet OLM 1990 Crystal agglomeration is a major element in calcium oxalate urinary stone formation. Kidney Int 37: 51-56
23. Ljunghall S, Fellstrom B, Johansson G 1988 Prevention of renal stones by a high fluid intake? Eur Urol 14: 381-385
24. Maikranz P, Holley JL, Parks JH, Lindheimer Md, Nakagawa Y, Coe FL 1989 Gestational hypercalciuria causes pathological urine calcium oxalate supersaturations. Kidney Int 36: 108-113
25. Mandel N 1996 Mechanism of stone formation Seminars in Nephrology 16: 364-374
26. Marshall VR 1996 The simple investigation and medical treatment of renal calculi. Australian Prescriber 19: 94-97
27. Michelacci YM, Glashan RQ, Schor N 1989 Urinary excretion of glycosaminoglycans in normal and stone forming subjects. Kidney Int 36: 1022-1028
28. Milliner DS, Eickholt JT, Bergstralh KJ, Wilson DM, Smith LH 1994 Results of long-term treatment with orthophosphate and pyridoxine in patients with primary hyperoxaluria N Engl J Med 331: 1553-1558
29. Monk RD 1996 Clinical approach to adults. Seminars in nephrology 16: 375
30. Morse RM, Resnick MI 1988 Urinary stone matrix. J Urol 139: 602-606
31. Nicar MJ, Hill K, Pak CYC 1983 A simple technique for the assessment of the propensity for the crystallisation of calcium oxalate and brushite in urine from the increment in oxalate or calcium necessary to elicit precipitation. Metabolism 32: 906-910
32. Pak CYC 1997 Southwestern infernal medicine conference - Medical Management of Nephrolithiasis - a new, simplified approach for general practice. Am J Medical Sci 313: 215-219
33. Pak CYC 1998 Kidney Stones. Lancet 351: 1797-1800
34. Pak CYC, Fuller C 1986 Idiopathic hypocitraturic calcium oxalate nephrolithiasis successfully treated with potassium citrate. Ann Intern Med 104: 33-37
35. Pak CYC, Hayashi Y, Finlayson B, Chu S 1977 Estimation of the state of saturation of brushite and calcium oxalate in urine: a comparison of three methods. J Lab Clin Med 89: 891-901
36. Pak CYC, Galosy RA 1980 Propensity for spontaneous nucleation of calcium oxalate. Quantitative assessment by urinary FPR-APR discrimination score. Am J Med 69: 681-689
37. Riddick T 1968 Control of colloid stability through zeta potential. Livingstone, Pennsylvania
38. Robertson WG 1969 Measurement of ionised calcium in biological fluies: Clin Chim Acta 24: 149-157
39. Robertson WG, Peacock M, Nordin BEC 1968 Activity products in stone-forming and non-stoneforming urine. Clin Sci 34: 579-594
40. Robertson WG, Peacock M, Nordin BEC 1969 Calcium crystalluria in recurrent renal stone formers. Lancet II: 21-24
41. Robertson WG, Peacock M, Marshall RW, Marshall DH, Nordin C 1976 Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract. New Eng J Med 294: 249-252
42. Robertson WG, Peacock M, Marshall RW, Heyburn PJ, Marshall DH, Clark PB 1978 Risk factors in calcium stone disease of the urinary tract. Brit J Urology 50: 449-454
43. Rogers AL, Spector M 1987 Morphogenesis and Pathogenesis of Urolithiasis in Stone Disease: Diagnosis and Management. In: Rous SN (ed). Grune and Startton, Orlando, pp 57-59
44. Röhrborn C, Schneider H-J, Rugendorff EW 1985 Determination of stone forming risk by measuring crystallisation inhibitor activity in urine with a gel model. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W: Urolithiasis and Related Clinical Research. Plenum Press, New York, 879-882
45. Tiselius HG 1989 Standardized estimate of the ion activity product of calcium oxalate in urine from renal stone formers. Eur Urol 16: 48-50
46. Werness PG, Bergert JH, Smith LH 1981 Crystalluria. J Crystal Growth 53: 166-181
47. Werness PG, Brown CM, Smith LH, Finlayson B 1985 EQUIL2: a basic computer program for the calculation of urinary saturation. J Urol 134: 1242-1244
48. Williams HE 1978 Oxalic acid and the hyperoxaluric syndromes. Kidney Int 13: 410-417
49. Worcester EM 1996 Inhibitors of stone formation. Seminars in Nephrology 16: 474-486